Baird Financial Group, Inc. Meridian Bioscience Inc Transaction History

Baird Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$23.75 - $31.69 $1,045 - $1,394	-44 Reduced 0.3%	14,781 $450,000
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $6,749 - $9,105	-338 Reduced 2.23%	14,825 $385,000
Q4 2021 Feb 09, 2022	SELL	$17.46 - $21.61 $87 - $108	-5 Reduced 0.03%	15,163 $310,000
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $263,164 - $341,280	15,168 New	15,168 $292,000
Q3 2020 Nov 12, 2020	SELL	$13.54 - $26.41 $1.6 Million - $3.12 Million	-118,173 Closed	0 $0
Q2 2020 Oct 22, 2020	SELL	$7.84 - $23.29 $32,112 - $95,395	-4,096 Reduced 3.35%	118,173 $2.75 Million
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $958,588 - $2.85 Million	122,269 New	122,269 $2.79 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.